CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • FLAK
      • VisionGraft
      • Sclera
    • Reimbursement Assistance
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Products
    • Products Overview
    • Corneal Products
      • EndoSerter-PL
      • EndoSerter
      • Cannula
      • Geuder Pre-Loaded Glass Cannula
      • Donor Punch
      • Recipient Trephine
      • Intacs
  • Innovation
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Gift of Sight
    • Core Commitments
    • Careers
    • Our Locations
    • News & Events
Request Tissue Contact Us
Patrick Lally

Patrick Lally

April 12, 2022

Patrick Lally is a partner at Petrichor Healthcare Capital Management, a life sciences-focused investment firm. Prior to joining Petrichor, Mr. Lally was a vice president at OrbiMed Advisors in their healthcare special situations and structured finance practice. Before OrbiMed, Mr. Lally was a healthcare investor in the Drawbridge Special Opportunities Fund at Fortress Investment Group. Mr. Lally holds an M.B.A. from The Wharton School at the University of Pennsylvania and an A.B. in Molecular Biology from Princeton University.

Recent Articles

  • AAO 2022 – Chicago, IL

    AAO 2022 – Chicago, IL

    AAO 2022 will take place in McCormick Place, Chicago. AAO 2022...

    READ MORE
  • CorneaGen Advances Next Generation of DSEK Surgery Innovation

    CorneaGen Advances Next Generation of DSEK Surgery Innovation

    New FDA approved, pre-loaded cornea graft insertion device maximizes efficiency...

    READ MORE
  • ASCRS 2022 – Washington, D.C.

    ASCRS 2022 – Washington, D.C.

    This meeting, focused on therapeutic, surgical, and administrative topics directly...

    READ MORE
  • Ziemer USA Announces Partnership with CorneaGen

    Ziemer USA Announces Partnership with CorneaGen

    Ziemer USA, a wholly owned subsidiary of Switzerland-based Ziemer AG,...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2022 CorneaGen

CorneaGen